408 related articles for article (PubMed ID: 12011019)
1. Differences in innate immune responses (in vitro) to HeLa cells infected with nondisseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis.
Dessus-Babus S; Darville TL; Cuozzo FP; Ferguson K; Wyrick PB
Infect Immun; 2002 Jun; 70(6):3234-48. PubMed ID: 12011019
[TBL] [Abstract][Full Text] [Related]
2. Chlamydial infection of polarized HeLa cells induces PMN chemotaxis but the cytokine profile varies between disseminating and non-disseminating strains.
Dessus-Babus S; Knight ST; Wyrick PB
Cell Microbiol; 2000 Aug; 2(4):317-27. PubMed ID: 11207588
[TBL] [Abstract][Full Text] [Related]
3. Sustained interleukin-6 and interleukin-8 expression following infection with Chlamydia trachomatis serovar L2 in a HeLa/THP-1 cell co-culture model.
Mpiga P; Mansour S; Morisset R; Beaulieu R; Ravaoarinoro M
Scand J Immunol; 2006 Mar; 63(3):199-207. PubMed ID: 16499573
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection.
Darville T; O'Neill JM; Andrews CW; Nagarajan UM; Stahl L; Ojcius DM
J Immunol; 2003 Dec; 171(11):6187-97. PubMed ID: 14634135
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis infection.
Gervassi A; Alderson MR; Suchland R; Maisonneuve JF; Grabstein KH; Probst P
Infect Immun; 2004 Dec; 72(12):7231-9. PubMed ID: 15557648
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-Dioxygenase Cannot Inhibit
Virok DP; Tömösi F; Keller-Pintér A; Szabó K; Bogdanov A; Poliska S; Rázga Z; Bruszel B; Cseh Z; Kókai D; Paróczai D; Endrész V; Janáky T; Burián K
Front Immunol; 2021; 12():717311. PubMed ID: 34819931
[TBL] [Abstract][Full Text] [Related]
7. Activation of neutrophils by Chlamydia trachomatis-infected epithelial cells is modulated by the chlamydial plasmid.
Lehr S; Vier J; Häcker G; Kirschnek S
Microbes Infect; 2018 May; 20(5):284-292. PubMed ID: 29499390
[TBL] [Abstract][Full Text] [Related]
8.
Faris R; Andersen SE; McCullough A; Gourronc F; Klingelhutz AJ; Weber MM
Front Cell Infect Microbiol; 2019; 9():399. PubMed ID: 32039039
[No Abstract] [Full Text] [Related]
9. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells.
Roshick C; Wood H; Caldwell HD; McClarty G
Infect Immun; 2006 Jan; 74(1):225-38. PubMed ID: 16368976
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition.
Perry LL; Su H; Feilzer K; Messer R; Hughes S; Whitmire W; Caldwell HD
J Immunol; 1999 Mar; 162(6):3541-8. PubMed ID: 10092812
[TBL] [Abstract][Full Text] [Related]
11. Expression of interferon regulatory factors and indoleamine 2,3-dioxygenase in Chlamydia trachomatis-infected synovial fibroblasts.
Rödel J; Groh A; Hartmann M; Schmidt KH; Lehmann M; Lungershausen W; Straube E
Med Microbiol Immunol; 1999 May; 187(4):205-12. PubMed ID: 10363677
[TBL] [Abstract][Full Text] [Related]
12. Less inhibition of interferon-gamma to organism growth in host cells may contribute to the high susceptibility of C3H mice to Chlamydia trachomatis lung infection.
Qiu H; Yang J; Bai H; Fan Y; Wang S; Han X; Chen L; Yang X
Immunology; 2004 Apr; 111(4):453-61. PubMed ID: 15056383
[TBL] [Abstract][Full Text] [Related]
13. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.
Ramsey KH; Cotter TW; Salyer RD; Miranpuri GS; Yanez MA; Poulsen CE; DeWolfe JL; Byrne GI
Infect Immun; 1999 Jun; 67(6):3019-25. PubMed ID: 10338514
[TBL] [Abstract][Full Text] [Related]
14. Chlamydia trachomatis induces anti-inflammatory effect in human macrophages by attenuation of immune mediators in Jurkat T-cells.
Azenabor AA; Cintrón-Cuevas J; Schmitt H; Bumah V
Immunobiology; 2011 Dec; 216(12):1248-55. PubMed ID: 21802168
[TBL] [Abstract][Full Text] [Related]
15. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia trachomatis infection increases the expression of inflammatory tumorigenic cytokines and chemokines as well as components of the Toll-like receptor and NF-κB pathways in human prostate epithelial cells.
Sellami H; Said-Sadier N; Znazen A; Gdoura R; Ojcius DM; Hammami A
Mol Cell Probes; 2014 Aug; 28(4):147-54. PubMed ID: 24613856
[TBL] [Abstract][Full Text] [Related]
17. Perforin-2 restricts growth of Chlamydia trachomatis in macrophages.
Fields KA; McCormack R; de Armas LR; Podack ER
Infect Immun; 2013 Aug; 81(8):3045-54. PubMed ID: 23753625
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of interferon-mediated inhibition of Chlamydia infection by interleukin-1 in human macrophage cultures.
Carlin JM; Weller JB
Infect Immun; 1995 May; 63(5):1870-5. PubMed ID: 7537250
[TBL] [Abstract][Full Text] [Related]
19. The Gram-negative bacterium Chlamydia trachomatis L2 stimulates tumor necrosis factor secretion by innate immune cells independently of its endotoxin.
Prebeck S; Brade H; Kirschning CJ; da Costa CP; Dürr S; Wagner H; Miethke T
Microbes Infect; 2003 May; 5(6):463-70. PubMed ID: 12758273
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cells.
Buckner LR; Lewis ME; Greene SJ; Foster TP; Quayle AJ
Cytokine; 2013 Aug; 63(2):151-65. PubMed ID: 23673287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
